Clinical Trial Update: Impact of Vitamin D Supplementation on Host Immunity to Mycobacterium Tuberculosis and Response to Treatment [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluating vitamin D supplementation's impact on host immunity to tuberculosis and response to treatment has completed. The study investigate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• Vitamin D3 (Cholecalciferol) (Cholecalciferol)

Snippet

Sponsor: Emory University | Conditions: Tuberculosis | Phase 2 | Status: COMPLETED